index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique

Dernières publications

Chiffres clés

52 Publications avec texte intégral

Open Access

75 %

Mots clés

Activin Receptors CaV subunits Dystrophie musculaire de Becker LncRNA Genomic Gene modifiers Multi resolution modeling Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Muscle hypertrophy Exon skipping Becker Muscular Dystrophy Morphogenesis Humans CaVβs Duchenne muscular dystrophy Mice Muscle development Dynamin 2 Connexins Becker muscular dystrophy DHPR α1S CTNNB1 Multi exon skipping Animal/physiopathology Ex-vivo Dystrophine Dystrophin Long noncoding RNA Human Umbilical Vein Endothelial Cells Adult muscle stem cells Duchenne DMD dystrophy Cell Line Drp1 Metabolism Cultured Homeostasis Dystrophin central domain Calcium Inhibitors Energy Metabolism/drug effects Inbred C57BL Dilated Cardiomyopathy Skeletal muscle Mdx mouse Multiresolution modeling Dystrophie Musculaire de Becker BMD MES Becker BMD muscular dystrophy Cells Modificateurs de gènes LKB1 Base Sequence MiARN Knockout Muscle Biology Muscle Delivery Invivo Molecular Sequence Data Dystrophy Diseases Dystrophin-EGFP Becker muscular dystrophy BMD Centronuclear myopathy Calcium Channels L-Type CD38 Liver Cell homeostasis Hear Duchenne muscular dystrophy DMD Cardiomyopathy Heart Failure Autophagy Allele‐specific silencing therapy Cachexia Molecular docking Génomique Muscle Strength BMD Mitochondrial fission Long QT Dystrophie Musculaire de Duchenne DMD Antisense oligonucleotides Epigenetics Cell Biology Muscle damage Cardiomyopathie Muscle cell fusion Immunoglobulin Fc Fragments/pharmacology Animals Male DMD Inbred mdx Gene expression LncARN Clinical trials Gene Expression Regulation/drug effects DMO Hepatocellular carcinoma